Options volume on call strikes outpaced puts by 3:1, signaling bullish bets ahead of next week’s investor healthcare conference. Analysts highlight strong prescription growth in North America as a key driver. Tilray ( TLRY ) , a global lifestyle and consumer packaged goods company with a significant cannabis segment, reacted optimistically to the probable legalization of cannabis at the federal level. “I don’t like it,” Mr. Doustdar said of the company’s share price drop on a call with reporters. “I don’t like it as an employee. I don’t like it as a C.E.O.-elect, and I certainly don’t like it as a shareholder myself.” Ozempic stock price has posted a 5% gain over the past month, outperforming the broader pharmaceutical index. With market chatter on expanded insurance coverage for weight-loss treatments, traders see potential for further upward re-rating if policy changes materialize.
